CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee, Kyung Joo Cho, Soon Young Shin, Ha Yan Kim, Eun Ju Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
J Liver Cancer. 2019;19(2):108-116.   Published online September 30, 2019
DOI: https://doi.org/10.17998/jlc.19.2.108

Excel Download

Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee, Kyung Joo Cho, Soon Young Shin, Ha Yan Kim, Eun Ju Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han
Journal of Liver Cancer. 2019;19(2):108-116   Crossref logo
Link1 Link2 Link3
Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma
Xu-Ren Sheng, Song-Ge Xing, Run-Dong Wang, Kang Chen, Wei-Dong Jia
OncoTargets and Therapy. 2018;Volume 11:909-917   Crossref logo
Link1 Link2
Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
Yanyan Wei, Wei Ye, Wei Zhao
Frontiers in Physiology. 2018;9:   Crossref logo
Link1
Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients
Fumio Nomura, Kunihiko Ohnishi, Yuichi Tanabe
Cancer. 1989;64(8):1700-1707   Crossref logo
Link1 Link2
Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Tampaki, Ionas, Hadziyannis, Deutsch, Malagari, Koskinas
Cancers. 2020;12(1):212   Crossref logo
Link1
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Jian-Hong Zhong, Cheng-Piao Luo, Chun-Yan Zhang, Le-Qun Li
Journal of Hepatocellular Carcinoma. 2016;Volume 4:11-13   Crossref logo
Link1 Link2
Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy
W.-Y. Kao, Y.-Y. Chiou, H.-H. Hung, C.-W. Su, Y.-H. Chou, J.-C. Wu, T.-I. Huo, Y.-H. Huang, W.-C. Wu, H.-C. Lin, S.-D. Lee
Clinical Radiology. 2012;67(5):429-436   Crossref logo
Link1 Link2
Elevated levels of serum pancreatic polypeptide in patients with hepatocellular carcinoma (HCC)
C SOLDEVJLAPICO
Hepatology. 1993;18(4):A194   Crossref logo
Link1 Link2
P2-041: Serum levels of novel adipokines in patients with hepatocellular carcinoma
Journal of Viral Hepatitis. 2018;25:129-129   Crossref logo
Link1 Link2
Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
Koji Uchino, Ryosuke Tateishi, Ryo Nakagomi, Naoto Fujiwara, Tatsuya Minami, Masaya Sato, Kenichiro Enooku, Hayato Nakagawa, Yoshinari Asaoka, Yuji Kondo, Junji Shibahara, Shuichiro Shiina, Kazuhiko Koike
PLOS ONE. 2018;13(7):e0200943   Crossref logo
Link1